QuantiFERON Change During Anti-tuberculosis Medication

The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01038830

Enrollment

Registered

2009-12-24

Start date

2008-05-31

Completion date

2010-05-31

Last updated

2010-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interferon-gamma Release Assay, Tuberculosis

Brief summary

The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.

Detailed description

Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All subjects with active tuberculosis

Exclusion criteria

* Subjects who cannot complete study * Subjects who have taken anti-tuberculosis medication for more than a month before visit of our hospital

Countries

South Korea

Outcome results